SALL4 is a Key Regulator of Survival and Apoptosis in Human Leukemic Cells

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2008 May 20

PMID 18487508

Citations 74

Authors

Jianchang Yang

Li Chai

Chong Gao

Taylor C Fowles

Zaida Alipio

Hien Dang

Dan Xu

Louis M Fink

David C Ward

Yupo Ma

Affiliations

Soon will be listed here.

Abstract

Increasing studies suggest that SALL4 may play vital roles in leukemogenesis and stem cell phenotypes. We have mapped the global gene targets of SALL4 using chromatin immunoprecipitation followed by microarray hybridization and identified more than 2000 high-confidence, SALL4-binding genes in the human acute promyelocytic leukemic cell line, NB4. Analysis of SALL4-binding sites reveals that genes involved in cell death, cancer, DNA replication/repair, and cell cycle were highly enriched (P < .05). These genes include 38 important apoptosis-inducing genes (TNF, TP53, PTEN, CARD9, CARD11, CYCS, LTA) and apoptosis-inhibiting genes (Bmi-1, BCL2, XIAP, DAD1, TEGT). Real-time polymerase chain reaction has shown that expression levels of these genes changed significantly after SALL4 knockdown, which ubiquitously led to cell apoptosis. Flow cytometry revealed that reduction of SALL4 expression in NB4 and other leukemia cell lines dramatically increased caspase-3, annexin V, and DNA fragmentation activity. Bromodeoxyuridine-incorporation assays showed decreased numbers of S-phase cells and increased numbers of G1- and G2-phase cells indicating reduced DNA synthesis, consistent with results from cell proliferation assays. In addition, NB4 cells that express low levels of SALL4 have significantly decreased tumorigenecity in immunodeficient mice. Our studies provide a foundation in the development of leukemia stem cell-specific therapy by targeting SALL4.

Citing Articles

Aberrant stem cell and developmental programs in pediatric leukemia.

Ling R, Cross J, Roy A Front Cell Dev Biol. 2024; 12:1372899.

PMID: 38601080 PMC: 11004259. DOI: 10.3389/fcell.2024.1372899.

Prognostic utility of TME-associated genes in pancreatic cancer.

Nie Y, Xu L, Bai Z, Liu Y, Wang S, Zeng Q Front Genet. 2023; 14:1218774.

PMID: 37727377 PMC: 10505756. DOI: 10.3389/fgene.2023.1218774.

Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome.

Tatetsu H, Watanabe M, Liu J, Tokunaga K, Iwanaga E, Komohara Y Clin Transl Med. 2023; 13(8):e1327.

PMID: 37501279 PMC: 10374880. DOI: 10.1002/ctm2.1327.

The new advance of SALL4 in cancer: Function, regulation, and implication.

Abouelnazar F, Zhang X, Wang M, Zhang J, Yu D, Zang X J Clin Lab Anal. 2023; 37(9-10):e24927.

PMID: 37337914 PMC: 10388233. DOI: 10.1002/jcla.24927.

SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway.

Zhou J, Peng S, Fan H, Li J, Li Z, Wang G Cancer Med. 2023; 12(12):13471-13485.

PMID: 37119046 PMC: 10315722. DOI: 10.1002/cam4.5998.

References

Zhou Q, Chipperfield H, Melton D, Wong W . A gene regulatory network in mouse embryonic stem cells. Proc Natl Acad Sci U S A. 2007; 104(42):16438-43. PMC: 2034259. DOI: 10.1073/pnas.0701014104. View

Elling U, Klasen C, Eisenberger T, Anlag K, Treier M . Murine inner cell mass-derived lineages depend on Sall4 function. Proc Natl Acad Sci U S A. 2006; 103(44):16319-24. PMC: 1637580. DOI: 10.1073/pnas.0607884103. View

Berezovska O, Glinskii A, Yang Z, Li X, Hoffman R, Glinsky G . Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle. 2006; 5(16):1886-901. DOI: 10.4161/cc.5.16.3222. View

Lessard J, Sauvageau G . Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 2003; 423(6937):255-60. DOI: 10.1038/nature01572. View

Ma Y, Cui W, Yang J, Qu J, Di C, Amin H . SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood. 2006; 108(8):2726-35. PMC: 1895586. DOI: 10.1182/blood-2006-02-001594. View

Lee K, Adhikary G, Balasubramanian S, Gopalakrishnan R, McCormick T, Dimri G . Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. J Invest Dermatol. 2007; 128(1):9-17. PMC: 3043461. DOI: 10.1038/sj.jid.5700949. View

Cui H, Hu B, Li T, Ma J, Alam G, Gunning W . Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol. 2007; 170(4):1370-8. PMC: 1829469. DOI: 10.2353/ajpath.2007.060754. View

Park I, Qian D, Kiel M, Becker M, Pihalja M, Weissman I . Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003; 423(6937):302-5. DOI: 10.1038/nature01587. View

Molofsky A, Pardal R, Iwashita T, Park I, Clarke M, Morrison S . Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 2003; 425(6961):962-7. PMC: 2614897. DOI: 10.1038/nature02060. View

10.

Jacobs J, Kieboom K, Marino S, DePinho R, van Lohuizen M . The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 1999; 397(6715):164-8. DOI: 10.1038/16476. View

11.

Mancini F, Gentiletti F, DAngelo M, Giglio S, Nanni S, DAngelo C . MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis. J Biol Chem. 2003; 279(9):8169-80. DOI: 10.1074/jbc.M311793200. View

12.

Wu Q, Chen X, Zhang J, Loh Y, Low T, Zhang W . Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J Biol Chem. 2006; 281(34):24090-4. DOI: 10.1074/jbc.C600122200. View

13.

Cui W, Kong N, Ma Y, Amin H, Lai R, Chai L . Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia. Mod Pathol. 2006; 19(12):1585-92. DOI: 10.1038/modpathol.3800694. View

14.

Mihara K, Chowdhury M, Nakaju N, Hidani S, Ihara A, Hyodo H . Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis. Blood. 2005; 107(1):305-8. DOI: 10.1182/blood-2005-06-2393. View

15.

Kohlhase J, Heinrich M, Schubert L, Liebers M, Kispert A, Laccone F . Okihiro syndrome is caused by SALL4 mutations. Hum Mol Genet. 2002; 11(23):2979-87. DOI: 10.1093/hmg/11.23.2979. View

16.

Kohlhase J, Schuh R, Dowe G, Kuhnlein R, Jackle H, Schroeder B . Isolation, characterization, and organ-specific expression of two novel human zinc finger genes related to the Drosophila gene spalt. Genomics. 1996; 38(3):291-8. DOI: 10.1006/geno.1996.0631. View

17.

Bieda M, Xu X, Singer M, Green R, Farnham P . Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res. 2006; 16(5):595-605. PMC: 1457046. DOI: 10.1101/gr.4887606. View

18.

Boyer L, Lee T, Cole M, Johnstone S, Levine S, Zucker J . Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005; 122(6):947-56. PMC: 3006442. DOI: 10.1016/j.cell.2005.08.020. View

19.

van der Lugt N, Domen J, Linders K, van Roon M, Te Riele H, van der Valk M . Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 1994; 8(7):757-69. DOI: 10.1101/gad.8.7.757. View

20.

Lowry W, Richter L, Yachechko R, Pyle A, Tchieu J, Sridharan R . Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A. 2008; 105(8):2883-8. PMC: 2268554. DOI: 10.1073/pnas.0711983105. View